# Study to Compare the Safety and Pharmacokinetics of CKD-330 8/5mg With Coadministration of the Two Separate Drugs

> **NCT02548286** · PHASE1 · COMPLETED · sponsor: **Chong Kun Dang Pharmaceutical** · enrollment: 53 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Candesartan 8mg
- **DRUG:** Amlodipine 5mg
- **DRUG:** CKD-330 8/5mg

## Key facts

- **NCT ID:** NCT02548286
- **Lead sponsor:** Chong Kun Dang Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2015-08
- **Final completion:** 2015-09
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2015-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02548286

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02548286, "Study to Compare the Safety and Pharmacokinetics of CKD-330 8/5mg With Coadministration of the Two Separate Drugs". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02548286. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*